NCT04440774View on ClinicalTrials.gov

Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 23, 2020

Primary Completion Date

February 18, 2022

Study Completion Date

February 18, 2022

Conditions
ChikungunyaZika
Interventions
BIOLOGICAL

CHIK low dose

A single dose of 5x10\^9 vp ChAdOx1 Chik

BIOLOGICAL

CHIK mid dose

A single dose of 2.5x10\^10 vp ChAdOx1 Chik

BIOLOGICAL

CHIK high dose

A single dose of 5x10\^10 vp ChAdOx1 Chik

BIOLOGICAL

ZIKA low dose

A single dose of 5x10\^9 vp ChAdOx1 Zika

BIOLOGICAL

ZIKA mid dose

A single dose of 2.5x10\^10 vp ChAdOx1 Zika

BIOLOGICAL

ZIKA high dose

A single dose of 5x10\^10 vp ChAdOx1 Zika

BIOLOGICAL

Saline placebo

A single dose of isotonic saline solution (0.9%)

Trial Locations (1)

64460

"Hospital Universitario Dr. José Eleuterio González de la Universidad Autónoma de Nuevo León.", Monterrey

All Listed Sponsors
lead

University of Oxford

OTHER

NCT04440774 - Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico. | Biotech Hunter | Biotech Hunter